189 related articles for article (PubMed ID: 9166453)
1. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
[TBL] [Abstract][Full Text] [Related]
2. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
Teicher BA; Holden SA; Jacobs JL
Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization of murine tumors by Fluosol-DA 20%.
Lee I; Levitt SH; Song CW
Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
[TBL] [Abstract][Full Text] [Related]
4. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
Lee I; Levitt SH; Song CW
Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
[TBL] [Abstract][Full Text] [Related]
5. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
Teicher BA; Crawford JM; Holden SA; Cathcart KN
Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
[TBL] [Abstract][Full Text] [Related]
6. Optimization of perfluorochemical levels with radiation therapy in mice.
Teicher BA; Herman TS; Jones SM
Cancer Res; 1989 May; 49(10):2693-7. PubMed ID: 2713854
[TBL] [Abstract][Full Text] [Related]
7. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
Morton JD; Porter E; Yabuki H; Nath R; Rockwell S
Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353
[TBL] [Abstract][Full Text] [Related]
8. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
Teicher BA; Holden SA; al-Achi A; Herman TS
Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928
[TBL] [Abstract][Full Text] [Related]
9. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
10. [Radiosensitization of Lewis lung tumor by perfluorochemical emulsion comparison between single and fractionated irradiation].
Hishikawa-itoh Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):781-7. PubMed ID: 2142500
[TBL] [Abstract][Full Text] [Related]
11. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
Hishikawa-Itoh Y; Kato T; Niwa T; Ayakawa Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1243-8. PubMed ID: 2794648
[TBL] [Abstract][Full Text] [Related]
12. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
Teicher BA; Holden SA
Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
[TBL] [Abstract][Full Text] [Related]
13. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
[TBL] [Abstract][Full Text] [Related]
14. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
Rockwell S; Mate TP; Irvin CG; Nierenburg M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
[TBL] [Abstract][Full Text] [Related]
15. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
Holden SA; Teicher BA; McIntosh NL; Rose CM
Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
[TBL] [Abstract][Full Text] [Related]
16. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
Teicher BA; Holden SA; Ara G; Ha CS; Herman TS; Northey D
J Cancer Res Clin Oncol; 1992; 118(7):509-14. PubMed ID: 1624542
[TBL] [Abstract][Full Text] [Related]
17. New high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation.
Thomas C; Lartigau E; Malaise EP; Guichard M
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1157-60. PubMed ID: 2497094
[TBL] [Abstract][Full Text] [Related]
18. Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide.
Teicher BA; Waxman DJ; Holden SA; Wang YY; Clarke L; Alvarez Sotomayor E; Jones SM; Frei E
Cancer Res; 1989 Sep; 49(18):4996-5001. PubMed ID: 2504483
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.
Holden SA; Teicher BA; Ha C; Ara G; Herman TS
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):895-8. PubMed ID: 1391529
[TBL] [Abstract][Full Text] [Related]
20. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
Brown JM; Lemmon MJ
Cancer Res; 1990 Dec; 50(24):7745-9. PubMed ID: 2253217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]